Analyst Price Targets — RXRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 17, 2025 7:14 am | — | Morgan Stanley | $11.00 | $4.20 | StreetInsider | JPMorgan Upgrades Recursion Pharmaceuticals (RXRX ) to Overweight |
| December 17, 2025 7:14 am | — | UBS | $11.00 | $4.20 | StreetInsider | JPMorgan Upgrades Recursion Pharmaceuticals (RXRX ) to Overweight |
| February 28, 2025 4:20 pm | — | Leerink Partners | $6.00 | $7.51 | TheFly | Recursion Pharmaceuticals price target lowered to $6 from $7 at Leerink |
| September 4, 2024 7:10 am | Gil Blum | Needham | $11.00 | $6.10 | StreetInsider | Recursion Pharmaceuticals (RXRX) PT Lowered to $11 at Needham |
| September 3, 2024 3:00 pm | Scott Schoenhaus | KeyBanc | $12.00 | $6.07 | StreetInsider | KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX ) |
| September 3, 2024 11:23 am | Dennis Ding | Jefferies | $6.00 | $6.02 | TheFly | Recursion Pharmaceuticals price target lowered to $6 from $8 at Jefferies |
| June 26, 2024 8:59 am | Scott Schoenhaus | KeyBanc | $16.00 | $8.76 | StreetInsider | KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX ) |
Latest News for RXRX
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Recursion Pharmaceuticals (RXRX) closed at $3.6 in the latest trading session, marking a -4% move from the prior day.
Recursion Pharmaceuticals (RXRX) closed at $3.32 in the latest trading session, marking a -2.06% move from the prior day.
Salt Lake City, April 07, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in the following upcoming investor conferences: 25th Annual Needham Virtual Healthcare Conference - Monday, April 13, 2026 Bank of America Health Care Conference 2026 - Tuesday, May 12, 2026 Webcasts may be found in the…
Recursion Pharmaceuticals (RXRX) reached $3.11 at the closing of the latest trading day, reflecting a +1.63% change compared to its last close.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RXRX.
U.S. House Trading
No House trades found for RXRX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.